Scientists at the University of Wisconsin and Theraclone Sciences in Seattle said they identified rare antibodies that proved effective in protecting 60% to 80% of mice from lethal doses of H1N1 and H5N1 flu viruses. The antibodies work by homing in on a part of the virus that does not have many mutations but is present in most influenza strains. They said the findings could pave the way for the development of a universal flu vaccine.

Full Story:

Related Summaries